ArticleInternational urology and nephrology2026
Expression analysis of epithelial membrane protein 1 (EMP1) gene in kidney stone patients.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCalcium oxalate (CaOx) nephrolithiasis is a recurrent urological disorder, and Randall's plaque (RP) of the renal papilla is widely accepted as an early site of stone nucleation. Although immune activation, epithelial injury, and extracellular matrix (ECM) remodeling have been reported in RP, the cell-type-specific transcriptional features of Epithelial Membrane Protein 1 (EMP1) in this tissue context remain undefined.
methodsA secondary, hypothesis-generating analysis of a publicly available single-cell RNA sequencing (scRNA-seq) dataset (NCBI GEO accession GSE176155; BioProject PRJNA735197) comprising renal papillary tissue from patients undergoing percutaneous nephrolithotomy for CaOx nephrolithiasis (RP samples) and matched normal renal papilla samples was performed. Raw FASTQ data were processed through Cell Ranger (v6.0.1) aligned to GRCh38, followed by quality control, normalization, dimensionality reduction (PCA, UMAP), graph-based clustering, and cell-type annotation in Seurat (v4.0.5) using canonical markers cross-checked against the Kidney Cell Atlas. Differential expression at the single-cell level was assessed by the Wilcoxon rank-sum test with Bonferroni correction. Coexpression, functional enrichment (GO, KEGG), and weighted gene coexpression network analysis (WGCNA) were used to characterise EMP1-associated transcriptional modules. Pseudobulk-style ANOVA and linear regression were performed as exploratory sensitivity checks at the sample level.
resultsAt the single-cell level, EMP1 was significantly downregulated in RP-derived epithelial and stromal clusters compared with normal renal papilla (adjusted p < 0.01, log2FC ≤ -0.30). EMP1 was co-expressed with C3, RNASE1, NRG1, IFI16, S100A10, HSPA6, and FN1, and the EMP1-correlated module identified by WGCNA was negatively correlated with the RP phenotype (r = -0.72, p < 0.001). GO and KEGG enrichment showed associations with cell adhesion, integrin and heparin binding, leukocyte migration, neutrophil extracellular trap formation, and focal adhesion. Sample-level pseudobulk ANOVA and regression analyses did not reach statistical significance for most genes, consistent with the limited number of donors and the loss of cell-type resolution after pseudobulk aggregation; these results are presented as exploratory.
conclusionsThis study reports an associative, hypothesis-generating link between reduced EMP1 expression in renal papillary epithelial and stromal populations and the molecular landscape of Randall's plaque. Independent transcriptomic, spatial, and functional validation will be required before EMP1 can be considered a candidate biomarker or therapeutic target in CaOx nephrolithiasis.
Indexed as
Identifiers
42271084What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.